The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers

Abstract

BackgroundLittle information is available regarding the burden of living with and managing epidermolysis bullosa, including the distinct challenges faced by patients with different disease types/subtypes.MethodsA 90-question/item survey was developed to collect demographics, diagnostic data, management practices, and burden of illness information for patients with epidermolysis bullosa living in the United States. Recruitment was conducted via email and social media in partnership with epidermolysis bullosa patient advocacy organizations in the United States, and the survey was conducted via telephone interview by a third-party health research firm. Respondents aged ≥ 18 years with a confirmed diagnosis of epidermolysis bullosa or caring for a patient with a confirmed diagnosis of epidermolysis bullosa were eligible to participate in the survey.ResultsIn total, 156 responses were received from patients (n = 63) and caregivers (n = 93) representing the epidermolysis bullosa types of simplex, junctional, and dystrophic (subtypes: dominant and recessive). A large proportion of patients (21%) and caregivers (32%) reported that the condition was severe or very severe, and 19% of patients and 26% of caregivers reported a visit to an emergency department in the 12 months prior to the survey. Among the types/subtypes represented, recessive dystrophic epidermolysis bullosa results in the greatest wound burden, with approximately 60% of patients and caregivers reporting wounds covering > 30% of total body area. Wound care is time consuming and commonly requires significant caregiver assistance. Therapeutic options are urgently needed and reducing the number and severity of wounds was generally ranked as the most important treatment factor.ConclusionsSurvey responses demonstrate that epidermolysis bullosa places a considerable burden on patients, their caregivers, and their families. The limitations caused by epidermolysis bullosa mean that both patients and caregivers must make difficult choices and compromises regarding education, career, and home life. Finally, survey results indicate that epidermolysis bullosa negatively impacts quality of life and causes financial burden to patients and their families.

Greater disease burden of variegate porphyria than hereditary coproporphyria: An Israeli nationwide study of neurocutaneous porphyrias

“…Studies of acute hepatic porphyria (AHP) described its detrimental effects on employment and ability to work [ 22 ], daily functioning and quality of life [ 15 ], often exacerbated by frequent repeated hospitalizations and unnecessary surgeries [ 8 ]. According to recent literature, over 60% of patients with acute hepatic porphyria experience chronic symptoms and 46% have daily symptoms [ 15 ].…”

Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation

“…The overall incidence of this rare autosomal recessive disease is estimated at 1 in 100,000 newborns worldwide [ 1 ]. However, significantly larger numbers of new patients have been reported in specific regions including the province of Quebec, Canada and Northern Europe, i.e., Finland and Norway [ 2 , 3 , 4 , 5 ]. HT1 is characterized by a defective or absent fumarylacetoacetate hydrolase (FAH) enzyme, the final enzyme of the tyrosine degradation pathway that is predominantly active in liver and kidney cells ( Figure 1 ) [ 6 , 7 ].…”

Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement Therapy

“…It is well known that cardiovascular dysfunction increases morbidity and mortality in these patients. However, the onset and extent of cardiovascular involvement differ for each MPS type [ 8 , 9 , 10 ]. Cardiac valve thickening, valvular regurgitation and stenosis, and cardiac hypertrophy are the most common cardiologic defects of MPS.…”